Galecto, Inc. (DMRA) vs Mineralys Therapeutics, Inc. (MLYS)
- Galecto, Inc. DMRA 23.67 +8.28%
- Mineralys Therapeutics, Inc. MLYS 15.35 +0.72%
Galecto, Inc. and Mineralys Therapeutics, Inc. are both Biotechnology companies. Galecto, Inc. and Mineralys Therapeutics, Inc. are of similar size ($1.4B and $1.4B). Mineralys Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Galecto, Inc. trades at 24.7×. Across the 9 metrics below, Galecto, Inc. leads on 6 and Mineralys Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | DMRA | MLYS | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (39.51%) | (80.88%) | (51.96%) |
| Return on assets | (27.08%) | (69.67%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack